Corona panic: researchers at the Migal Institute are optimistic about a vaccine they developed

After four years of research funded by the Ministry of Science and Technology, researchers at the Migal Institute of Coronary Virus Vaccine (IBV) developed successfully in preclinical trials and genetically modified for the corona virus vaccine.
Minister of Science and Technology Ophir Akunis welcomed the new revelations of the study: "Hope and believe there will be further progress soon." Minister Akunis instructed his office manager to quickly promote possible collaborations that would enable vaccines for humans as soon as possible.
After four years of research by Migal's multidisciplinary team of researchers, funded by the Ministry of Science and Technology and the Ministry of Agriculture, a scientific breakthrough for the vaccine against the corona virus was discovered during the research project for the vaccine of the Corona vaccine for Infectious Bronchitis Virus (IBV). In preclinical trials conducted at the Volcanic Institute, after adjusting for human coronary disease, COVID-19, Miguel is awaiting product safety approval to start producing vaccines against the world's most widespread disease, leaving 2,666 patients dead.
The research conducted at the Migal Research Institute by the researchers: Prof. Jacob Pitkowski, Dr. Chen Katz, Dr. Ehud Shahar and their team - indicates that the chicken virus in the poultry has a high genetic identity to the human COVID-19 virus. The study also found that the mechanism of infection of both viruses is the same, an important scientific fact that increases the chance of getting vaccinated in humans in a very short time.
David Zigdon, CEO of the Migal Research Institute, says: "There is a great urgency in the world to develop a human vaccine for the Corona virus, so we are working to accelerate the development process to reach an effective COVID-19 vaccine over the next 8-10 weeks and a 90-day safety trial. . The vaccine developed by us for poultry is oral and also the human vaccine offered by us is expected to be oral. "Zigdon also points out that due to the urgent global need for the Corona vaccine, marathon discussions are held with potential partners to help accelerate product research processes needed to complete the product. Final and regulatory activities.
Dr. Chen Katz, a principal researcher at the Migal Institute of Biotechnology, says that the scientific system developed by Migal is based on a new protein expression vector, which creates and secretes a soluble chimeric protein, which transmits the viral antigen to the mucosal tissues by endocytosis (antigen absorption into the cell). By imprisoning the cell membrane inwards and closing the vesicles, the body produces antibodies against the virus, and Migal has been able to prove in a preclinical (In-Vivo) trial that the use of the system creates antibodies specific for viral protein subunits and IBV virus resistance.
Migal - The Galilee Scientific Research Institute of the Galilee Development Company is a research and development center of the Ministry of Science and Technology, owned by the Galilee Development Company. Last year (2019), the Ministry of Science and Technology funded the institute about NIS 30 million for the research - which is about half of the institute's entire budget. The Miguel Institute for Worldwide Applied Scientific Research, specializing in biotechnology, computer science, agro-technology, agriculture, environmental science, nutrition, health and food. Miguel has ninety PhDs and 190 researchers, working in 44 research groups, each run by a senior lead researcher. Miguel's joint research facilities, nestled between the picturesque mountain scenery and the natural abundance of the Galilee, in an area characterized by a unique blend of rural and urban, agriculture and industrial, high-tech and traditional industries, provide an ideal environment for fostering innovation and knowledge sharing. Many years of close collaboration with industry leaders, innovative startups, and technology accelerators, along with contacts with visionary educators, scientists and entrepreneurs, have made Migal a unique regional power of applied research.

After four years of research funded by the Ministry of Science and Technology, researchers at the Miguel Institute of Coronary Virus Vaccine (IBV) developed successfully in preclinical trials and genetically modified for the corona virus vaccine.
Minister of Science and Technology Ophir Akunis welcomed the new revelations of the study: "Hope and believe there will be further progress soon." Minister Akunis instructed his office manager to quickly promote possible collaborations that would enable vaccines for humans as soon as possible.Yesterday the Ministry of Health expanded the requirement for home insulation and recommends that the public "consider the need for travel abroad following the spread of the Corona virus in Italy, where 12 people have died and 374 have already been infected with the virus. The ministry announced that as of Sunday, March 1, anyone returning from Italy in the last 14 days will be required to enter home isolation until they are completed 14 days from the date of their return.

"The said date is intended, among other things, to give enough time for Italians staying in Israel to leave Israel in an orderly manner," they explained. The Ministry of Health said: "The government has issued a comprehensive travel warning to Italy and in view of the morbidity there - we urge residents not to go to Italy."